Metraipolis › archive › dc_e68d587491a7

Pre-treatment cytokines plus TPSA predict biochemical progression-free survival in prostate cancer metastasis and discriminate metastatic status: a… — Europe PMC PMID:41394847

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41394847
DOI
10.3389/fimmu.2025.1686570
License (as archived)
solo-consultazione
Archived
2026-11-08T05:11:40.107Z
SHA-256 of the archived text
e1396f9a7c634063d3a74d20cc67c6be9f783a03ae768d523c342a61026b4f15
Stable URL of this page
https://metraipolis.com/documento/dc_e68d587491a7

How to cite

Pre-treatment cytokines plus TPSA predict biochemical progression-free survival in prostate cancer metastasis and discriminate metastatic status: a… — Europe PMC PMID:41394847 — Europe PMC (en), https://europepmc.org/article/MED/41394847 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e68d587491a7 (Metraipolis archive dc_e68d587491a7, sha256 e1396f9a7c634063d3a74d20cc67c6be9f783a03ae768d523c342a61026b4f15)
BibTeX
@misc{dce68d587491a7,
  title = {Pre-treatment cytokines plus TPSA predict biochemical progression-free survival in prostate cancer metastasis and discriminate metastatic status: a… — Europe PMC PMID:41394847},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41394847},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e68d587491a7; sha256 e1396f9a7c634063d3a74d20cc67c6be9f783a03ae768d523c342a61026b4f15},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41394847. Agents can read the archived copy with the MCP tool read_document.